Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation. by Lunsford, Keri E et al.
UCLA
UCLA Previously Published Works
Title
Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring 
transplantation.
Permalink
https://escholarship.org/uc/item/50w7m9b1
Journal
World journal of gastroenterology, 22(45)
ISSN
1007-9327
Authors
Lunsford, Keri E
Bodzin, Adam S
Reino, Diego C
et al.
Publication Date
2016-12-01
DOI
10.3748/wjg.v22.i45.10071
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Keri E Lunsford, Adam S Bodzin, Diego C Reino, Ronald 
W Busuttil, The Pfleger Liver Institute, The Dumont-UCLA 
Liver Transplant Center, Division of Liver and Pancreas 
Transplantation, Department of Surgery, David Geffen School of 
Medicine at UCLA, University of California Los Angeles, Los 
Angeles, CA 90095, United States
Keri E Lunsford, J.C Walter Jr. Center for Transplantation, 
Sherrie and Alan Conover Center for Liver Disease and 
Transplantation, Center for Transplantation Immunobiology, 
Houston Methodist Hospital and Research Institute, Houston, TX 
77030, United States
Hanlin L Wang, Department of Pathology and Laboratory 
Medicine, David Geffen School of Medicine at UCLA, 
University of California Los Angeles, Los Angeles, CA 90095, 
United States
Author contributions: Lunsford KE and Busuttil RW designed 
the report; Lunsford KE, Bodzin AS and Reino DC collected 
and analyzed the patient’s data; Wang HL performed histologic 
analysis; Lunsford KE wrote the paper, Lunsford KE, Bodzin 
AS, Reino DC and Busuttil RW performed critical review and 
revision of the manuscript.
Institutional review board statement: This is a case report, 
which, per the policies of the Institutional Review Board at the 
University of California, Los Angeles, is exempt from review.
Informed consent statement: The patient presented in this 
case report gave his written informed consent authorizing use and 
disclosure of his protected health information.
Conflict-of-interest statement: The authors report no 
conflicting interests (including but not limited to commercial, 
personal, political, intellectual or religious interests) relating to 
the present manuscript.
Open-Access: This article is an open-access article which was 
selected by an in-house editor and fully peer-reviewed by external 
reviewers. It is distributed in accordance with the Creative 
Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this 
work non-commercially, and license their derivative works on 
different terms, provided the original work is properly cited 
and the use is non-commercial. See: http://creativecommons.
org/licenses/by-nc/4.0/
Manuscript source: Unsolicited manuscript
Correspondence to: Keri E Lunsford, MD, PhD, J.C Walter 
Jr. Center for Transplantation, Sherrie and Alan Conover Center 
for Liver Disease and Transplantation, Center for Transplantation 
Immunobiology, Houston Methodist Hospital and Research 
Institute, 6670 Bertner Ave., Suite R7-416, Houston, TX 77030, 
United States. klunsford@houstonmethodist.org
Telephone: +1-713-4412038
Fax: +1-713-4417439
Received: April 27, 2016
Peer-review started: April 27, 2016
First decision: June 20, 2016
Revised: July 6, 2016
Accepted: August 5, 2016
Article in press: August 5, 2016
Published online: December 7, 2016
Abstract
Commercial dietary supplements are marketed as a 
panacea for the morbidly obese seeking sustainable 
weight-loss. Unfortunately, many claims cited by 
supplements are unsupported and inadequately 
regulated. Most concerning, however, are the 
associated harmful side effects, often unrecognized 
by consumers. Garcinia cambogia  extract and Garcinia 
cambogia  containing products are some of the most 
popular dietary supplements currently marketed for 
weight loss. Here, we report the first known case of 
fulminant hepatic failure associated with this dietary 
supplement. One active ingredient in this supplement 
is hydroxycitric acid, an active ingredient also found in 
weight-loss supplements banned by the Food and Drug 
Administration in 2009 for hepatotoxicity. Heightened 
awareness of the dangers of dietary supplements 
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CASE REPORT
Dangerous dietary supplements: Garcinia cambogia-
associated hepatic failure requiring transplantation
Keri E Lunsford, Adam S Bodzin, Diego C Reino, Hanlin L Wang, Ronald W Busuttil
such as Garcinia cambogia  is imperative to prevent 
hepatoxicity and potential fulminant hepatic failure in 
additional patients. 
Key words: Dietary supplements; Fulminant hepatic 
failure; Drug-induced liver injury; Liver transplantation; 
Hyroxycitric acid; Weight-loss supplements
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Core tip: The current regulatory practice for over-the-
counter dietary supplements in addition to celebrity 
endorsements of these products unfounded claims has 
resulted in a significant increase in the use of dietary 
supplements for weight loss. Unfortunately, several 
such products have previously been demonstrated to 
be serious health risks. Here we present one of the first 
known cases of fulminant hepatic failure associated 
with one such popular weight loss supplement, Garcinia 
cambogia .
Lunsford KE, Bodzin AS, Reino DC, Wang HL, Busuttil RW. 
Dangerous dietary supplements: Garcinia cambogia-associated 
hepatic failure requiring transplantation. World J Gastroenterol 
2016; 22(45): 10071-10076  Available from: URL: http://www.
wjgnet.com/1007-9327/full/v22/i45/10071.htm  DOI: http://
dx.doi.org/10.3748/wjg.v22.i45.10071
INTRODUCTION
Dietary supplements are an increasingly recognized 
cause of acute liver injury and fulminant hepatic 
failure. Under the Dietary Supplement Health and 
Education Act of 1994, supplements, unlike prescrip-
tion and over-the-counter medications, require proven 
toxicity prior to FDA sanctions[1]. The Drug Induced 
Liver Injury Network (DILIN) identifies dietary supple-
ments among the most common causes of drug-
induced hepatotoxicity. Nearly a quarter of cases 
suffer irreversible liver damage, resulting in potential 
liver transplant (4%) and death (6%)[2]. Evaluation of 
dietary supplement-induced hepatoxicity is difficult due 
to wide formulaic variations, and ineffectual federal 
manufacturing oversight allows contamination by 
alfatoxins, microorganisms, pesticides, heavy metals, 
and synthetic drugs. These contaminants have known 
hepatotoxicity and may contribute to detrimental 
effects[3]. In addition, following formal FDA citation, a 
supplement may be remarketed after minor reformu-
lation and/or rebranding. 
Of particular note has been hepatotoxicity associ-
ated with several different brands of “fat busters”. 
Commercial fat-burning dietary supplements are 
widely marketed as “miracle-cures” for obesity on 
major network television shows with celebrity endorse-
ments. Supplements are advertised to stimulate 
weight loss by increasing the body’s basal metabolic 
rate; however, campaigns are bereft of associated 
side effects (reviewed in[3,4]). Multiple companies 
manufacture supplements of the same name with dif-
ferent composition, contaminants, and concentrations 
of active ingredients, potentially resulting in variable 
hepatotoxicity. Effort made by the FDA to collect data 
regarding toxicities through “Safety Reporting Portal” 
in the MedWatch system[5] is reliant upon consumer 
and industry reporting compliance. As a result, recog-
nition of toxicities may arise slowly.
Garcinia cambogia (G. cambogia) containing prod-
ucts are currently one of the most highly marketed 
group of weight-loss supplements commercially avail-
able. The supplement is derived from the rind of the 
fruit of the Garcinia cambogia tree, which is native to 
southwestern India. It has gained significant acclaim 
for its weight-loss benefits through mainstream talk 
shows and medical media celebrity spokespeople. 
Here, we report the first known case of fulminant 
hepatic failure associated with dietary intake of a “pure” 
Garcinia cambogia supplement.
CASE REPORT
A 34-year old Hispanic male presented with nausea, 
vomiting, abdominal pain, and dark urine. Testing 
revealed elevated transaminases and bilirubin; howev-
er, imaging failed to demonstrate cirrhosis or anatomic 
abnormality. Hepatitis work-up, including testing for 
viral hepatitis, hemochromatosis, Wilson’s disease, and 
autoimmune hepatitis, was unremarkable with excep-
tion of an elevated Ferritin level of 7089 mg/dL. Genetic 
testing for hemochromatosis was negative. Medical his-
tory was only positive for occasional social alcohol use, 
and drug toxicology testing was negative. He denied 
use of energy drinks, herbs, Chinese teas, or muscle 
milk. He was advised to discontinue alcohol use, which 
he did, and his symptoms initially seemed to abate.
Six weeks later, the patient developed asterixis, 
jaundice, and confusion. Follow-up imaging was con-
cerning for rapid onset of cirrhosis or infiltrative hepa-
tocellular carcinoma. He was transferred to our center 
for further evaluation. On admission, transaminases 
were elevated with aspartate aminotransferase (AST) 
624 U/L, alanine aminotransferase (ALT) 520 U/L and 
total bilirubin of 34.7 mg/dL. International normalized 
ratio (INR) remained elevated despite multiple infu-
sions of fresh frozen plasma and vitamin K. Factor Ⅴ
and Ⅶ activities were 18% and < 6%, respectively. 
Magnetic resonance imaging (MRI) with Eovist contrast 
demonstrated interval development of heterogeneous, 
enhancing nodularity with portal venous washout, 
unlikely to be an infiltrative tumor process. 
A full repeat hepatitis work-up was performed (Table 
1). No definitive cause of acute liver failure could be 
identified; however, some findings were equivocal. 
Autoantibody titers demonstrated a positive anti-
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Laboratory test Result Reference range
Hepatic function panel
Aspartate aminotransferase 624 U/L (H) 7-36 U/L
Alanine aminotransferase 520 U/L (H) 4-45 U/L
Alkaline phosphatase 156 U/L (H) 31-103 U/L
Bilirubin, total 34.7 mg/dL (H) 0.2-1.1 mg/dL
Bilirubin, conjugated 14.8 mg/dL (H) 0.0-0.2 mg/dL
Albumin 3.6 g/dL (L) 3.7-5.1 g/dL
Total Protein 5.8 g/dL (L) 6.2-8.6 g/dL
Coagulation factors
Prothombin time 37.9 s (H) 9.1-11.9 s
INR 3.5 (H) < 1.2
Factor Ⅶ activity < 6% (L) > 50% activity
Factor Ⅴ activity 18% (L) > 50% activity
Tumor markers
CEA 2.3 ng/mL < 3.1 ng/mL
CA 19-9 235 U/mL (H) 0-35 U/mL
AFP 51.1 ng/mL (H) 1.6-4.5 ng/mL
AFP-L3 19.0% (H) 0.5%-9.9%
PIVKA 4.4 ng/mL < 6.3 ng/mL
Viral serologies
Hepatitis A, IgM Nonreactive Nonreactive
Hepatitis A, IgG Reactive1 Nonreactive
Hepatitis B surface antigen Nonreactive Nonreactive
Hepatitis B surface antibody, quantitative < 10 IU/L < 10 IU/L
Hepatitis B core antibody, total Nonreactive Nonreactive
Hepatitis C antibody screen Nonreactive Nonreactive
Hepatitis C RNA quantitative PCR Not Detected Not detected
Hepatitis E antibody, IgG Not Detected Not detected
Hepatitis E antibody, IgM Not Detected Not detected
CMV antibody immune status Positive1 Negative
CMV DNA quantitative PCR Not Detected Not detected
Liver tissue CMV in situ hybridization Negative Negative
EBV-VCA IgM Negative Negative
EBV-VCA IgG Positive1 Negative
EBV DNA quantitative PCR Not Detected Not detected
Liver tissue EBV in situ Hybridization Negative Negative
Adenovirus DNA Quantitative PCR Not Detected Not Detected
Liver tissue adenovirus in situ hybridization Negative Negative
Herpes Simplex 1 IgM screen Negative Negative
Herpes Simplex 2 IgM screen Negative Negative
Liver Tissue HSV 1 and 2 in situ hybridization Negative Negative
RPR Nonreactive Nonreactive
Autoantibody titer
Antinuclear antibody Positive1 Negative
Antinuclear antibody titer 1:401 < 1:20
Smooth muscle antibody < 1:20 < 1:20
Liver kidney microsome antibody IgG < 20.0 U < 20.0 U
Soluble liver antigen autoantibody < 20.1 U < 20.1 U
Wilson’s disease evaluation
Copper, RBC 0.71 mg/L 0.53-0.91 mg/L
Copper, serum 95 μg/dL 70-140 μg/dL
Ceruloplasmin 22 mg/dL 17-48 mg/dL
Copper, 24-h urine 1055 μg/d (H) 3-50 μg/day
Quantitative liver copper 47 μg/g tissue 10-55 μg/g tissue
Hemochromatosis evaluation
Total iron 243 μg/dL (H)2 23-202 μg/dL
Iron binding capacity < 308 μg/dL (L)3 240-520 μg/dL
Transferrin 163 mg/dL (L) 198-386 mg/dL
Ferritin 3254 ng/mL (H) 8-350 ng/mL
Alpha-1-antitrypsin 91 mg/dL 83-199 mg/dL
Acetaminophen < 10 μg/mL 10-20 μg/mL
1Indicates positive result; 2(H) indicates value above the reference range; 3(L) indicates value below the reference range. AFP: Alpha-fetoprotein; EBV: 
Epstein Barr virus; CEA: Carcinoembryonic antigen; CMV: Cytomegalovirus; CA 19-9: Carbohydrate antigen 19-9; AFP-L3: Lectin-reactive AFP percentage; 
HSV: Herpes simplex virus; INR: International normalized ratio; PCR: Polymerase chain reaction; PIVKA: Protein induced by vitamin K absence.
Table 1  Work-up for causes of acute liver failure in reported patient
Lunsford KE et al . Garcinia cambogia -associated hepatic failure
nuclear antibody, but no other positive autoantibodies. 
Evaluation of Wilson’s disease demonstrated normal 
ceruloplasmin and copper levels; however, 24-h urine 
copper was elevated. Serum ferritin but not transferrin 
was elevated.
Liver biopsy was performed and demonstrated 
submassive necrosis with collapse of the hepatic archi-
tecture involving about 70% of the liver parenchyma. 
Mild lymphocytic inflammatory infiltration and minimal 
canalicular cholestasis were seen. No viral inclusions 
or other infectious agents were identified by histology 
or immunohistochemistry. No evidence of granuloma, 
tumor, or features of cirrhosis were demonstrated. 
Periodic acid-Schiff (PAS) stain with diastase was 
negative for alpha-1 antitrypsin globules. Iron stain 
showed only mild iron deposition in Kupffer cells and 
hepatocytes. Quantitative tissue copper was within 
normal limits (Table 1). Findings were felt to be poten-
tially related to drug-induced liver injury.
After extensive questioning, the patient divulged 
intake of Garcinia cambogia, purchased through the 
Internet retailor Swanson Vitamins. He imbibed two 80 
mg capsules of “Garcinia Cambogia 5:1 Extract” three 
times daily before meals for five months preceding 
initial presentation. Since not advised against intake, 
he continued the supplement after initial presentation. 
He denied any other medications or supplements and 
reported no alcohol intake for two months.
The patient’s status declined and his mental status 
deteriorated. He was listed status 1A for liver trans-
plantation. He received an orthotopic liver transplant 
from an ABO-identical brain dead donor and has 
recovered without incident. Histopathologic examina-
tion of the explanted liver demonstrated near total 
hepatic necrosis with massive hepatocellular dropout 
and mixed inflammatory cell infiltrates, consistent with 
severe drug-induced liver injury (Figure 1).
DISCUSSION
Americans spent approximately 59.8 billion dollars 
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on weight loss products in 2014[6], and an estimated 
10.1% of obese Americans have purchased over-the-
counter supplements for weight-loss. Unfortunately, 
utilization does not correlate with sustained weight-
loss[7]. One product that has been heavily marketed as 
a “revolutionary fat buster” and a “magical ingredient” 
to promote weight loss is G. cambogia. This extract 
from the rind of the G. cambogia fruit is currently con-
tained in 655 currently marketed products according 
to the Natural Medicine Comprehensive Database[8]. 
These include “purified” supplement pills, multivita-
mins, and even energy drinks with widely disparate 
compositions, dosage, and potential contaminants.
The particular brand of Garcinia cambogia in 
this case was “Swanson Premium Brand Garcinia 
Cambogia 5:1 Extract,” reported to contain 80mg of a 
5:1 concentrate of G. cambogia (equivalent to 400mg 
of standard preparation). Other listed ingredients 
include rice flour, gelatin, magnesium stearate, and 
silica. The company reports that they do no assay 
for the hydroxycitric acid concentration, the fruit 
derivative reportedly responsible for weight-loss 
benefits of Garcinia cambogia[9]. This is of note since 
hydroxycitric acid is the main derivative thought to 
be responsible for the weight-loss benefits of Garcinia 
cambogia. Mechanistically, it acts to prevents citric acid 
metabolism resulting inhibition of de novo fatty acid 
synthesis[10]. 
G. cambogia was also a main active ingredient in 
the weight-loss supplement Hydroxycut® (Iovate Health 
Sciences, Inc., Oakville, ON), which has known hepa-
toxicity[11-16]. In May 2009, the FDA issued a consumer 
warning recalling all Hydroxycut® products due to 23 
hepatotoxicity cases. Prior to 2004, the formulation 
also contained ephedra, which was removed following 
the FDA ban. However, ten of 23 cases of hepatotoxic-
ity, including the patient death, occurred after the 2004 
reformulation to remove ephedra[17]. G. cambogia was 
present in Hydroxycut® following the 2004 reformula-
tion, but additional cases of hepatotoxicity occurred 
and a second FDA warning resulted in a second recall 
A B
Figure 1  Histopathologic evaluation of explanted liver with Garcinia Cambogia associated fulminant hepatitis. A: Histopathologic examination demonstrates 
large areas of panacinar necrosis with complete hepatocyte dropout, collapsed lobules, florid ductular reaction, and predominantly lymphocytic infiltrates (hematoxylin-
eosin stain, original magnification × 200); B: Non-necrotic areas demonstrate hepatocyte ballooning, cholestasis, and mild lymphocytic infiltration. Occasional 
apoptotic hepatocytes (acidophil bodies) were present (hematoxylin-eosin stain, original magnification × 400).
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in 2009. The supplement was again reformulated and 
remarketed. G. cambogia is absent from the currently 
marketed formulations of Hydroxycut®.
Although G.cambogia has been suggested as the 
putative cause of the banned supplement’s hepatotoxic 
effects[16], there is no definitive evidence. The majority 
of G. cambogia formulation associated with hepatotox-
icity have been mixed supplements were a definitive 
causal relation could not be drawn. However, in the 
past several months, several cases of G. cambogia 
associated acute liver failure have been reported[18,19], 
reinforcing the toxic potential of this particular supple-
ment. Agreement upon the actual liver toxicity of 
G. cambogia has been mixed, and the majority of 
evidence is drawn from rodent models[20]. The product 
can induce liver inflammation, fibrosis, and oxidative 
stress in mice. In one such study, supplement intake 
increased collagen deposition, elevated liver function 
tests, induced inflammatory cytokines, and stimulated 
oxygen free-radicals[21]. However, supplement advo-
cates cite rodent models in which G. cambogia dem-
onstrates hepatoprotective effects, including decreased 
hyperlipidemia and hepatic oxidative stress in rats fed 
with a high-fat diet[22]. 
This is one of the first reported cases of acute 
liver failure specifically associated with a “purified” 
supplement of G. cambogia. The patient had histologic 
evidence of drug-induced liver injury in the absence of 
other medication or alcohol use. Viral, autoimmune, 
and genetic (i.e., hemochromatosis and Wilson’s 
disease) causes of acute liver failure were definitively 
ruled-out, and G. cambogia intake was the only appar-
ent risk factor. Unfortunately, independent laboratory 
evaluation of the supplement was not performed, 
which could have identified potential contaminants 
and verified manufacturer reported composition. While 
evidence from a case report rarely offers indisputable 
proof of causality, this case, in conjunction with known 
cases of hepatotoxicity and liver failure associated with 
other G. cambogia-containing supplements warrants a 
high index of suspicion.
Conditions predisposing patients to liver toxicity 
associated with Garcinia cambogia and like products 
remain unidentified. Acute liver failure from supple-
ment ingestion appears relatively rare compared 
to their widespread use. Certain patients may have 
genetic predisposition or pre-existing liver damage, 
compounding hepatotoxicity. Cytochrome P450 is 
most commonly responsible for hepatic metabolism 
of drugs, and genetic polymorphisms in cytochrome 
P450 genes have previously be shown to result in 
toxic accumulation of certain drugs or metabolites. 
For example, toxicity associated with weight-loss 
supplements containing N-nitrofenfluramine has been 
associated with cytochrome CYP2C19 phenotypes[23]. 
Mitochondrial injury, suggesting of toxic accumulation 
of N-nitrofenfluramine, was associated with a poor 
metabolizer phenotype; while, mitochondrial injury 
was absent in extensive metabolizers of the drug. One 
extensive metabolizer developed hypersensitivity-
associated hepatitis related to drug ingestion; how-
ever, mitochondrial injury was absent. Toxicity to G. 
cambogia may have incomplete penetrance due to 
a similar dependence upon genetic polymorphisms. 
Alternatively, injury may be more likely as a second 
hit in the setting of pre-existing liver damage. At our 
institution, a second case of G. cambogia-associated 
acute liver failure was identified; however, the patient 
had a remote history of heavy binge drinking with final 
pathology suggestive of early fibrosis. Drug-induced 
hepatotoxicity could not be definitively diagnosed due 
to this history, but the association with ingestion of 
large quantities of G. cambogia was suspicious, given 
that the degree chronic liver disease insufficiently 
accounted for her acute hepatic failure.
While additional research is necessary to further 
identify the link between Garcinia Cambogia and 
severe liver damage, public warning to potentially 
deadly side effects is necessary. This case emphasizes 
the need for direct questioning regarding dietary 
supplement intake in any case of acute hepatic injury. 
Manufacturers compliance with current regulations 
regarding contaminants is insufficient to preclude 
consumer toxicity, and increased public awareness 
of these dangers is crucial. Current regulation and 
oversight of the dietary supplement market should 
be scrutinized to improve supplement purity and 
identification of dangers. Endorsements by medical 
media celebrities and claims of “miracle results” 
should be carefully monitored for veracity. This case 
bears concerning similarity to those of Hydroxycut-
associated liver failure, suggesting that although the 
product name may change, deadly side effects remain 
the same. 
COMMENTS
Case characteristics
The patient initially presented with symptoms of nausea, vomiting, abdominal 
pain, and symptoms progressed to include confusion, coagulopathy, and 
jaundice. 
Clinical diagnosis
Evaluation for viral, genetic, and antibody mediated causes of hepatitis were 
largely negative with histological evidence of near total hepatic necrosis on 
biopsy.
Differential diagnosis
Alternative autoimmune, viral, and genetic causes of acute liver failure must be 
excluded. In the absence of these, careful questioning regarding medications, 
herbal supplements, and energy drinks must be undertaken.
Laboratory diagnosis
Negative laboratory evaluation for autoimmune, viral, and genetic causes 
of acute liver failure in the presence of elevated liver function tests and 
coagulopathy should raise clinical suspicion for drug-induced liver injury.
Imaging diagnosis
Magnetic resonance imaging with Eovist contrast demonstrated interval 
development of heterogeneous, enhancing nodularity with portal venous 
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washout, unlikely to be an infiltrative tumor process.
Pathological diagnosis
Explant pathology demonstrated near total hepatic necrosis with massive 
hepatocellular dropout and mixed inflammatory cell infiltrates.
Treatment
Patient received liver transplantation with complete resolution of symptoms.
Related reports
Acute liver failure and severe hepatotoxicity has been associated multiple 
dietary supplements utilized for weight loss. These include the supplement 
Hydroxycut®, which was removed from the market by the FDA and has 
undergone several reformulations. 
Term explanation 
Garcinia cambogia - tree grown in southwestern India. Extracts from the rind of 
the fruit from this tree are high in hydroxycitric acid and are marketed as weight-
loss supplements.
Experiences and lessons
Careful questioning of any patient presenting with liver function abnormalities or 
acute liver failure should prompt questioning regarding dietary supplement and 
energy drink consumption. Patients with acute liver failure should be promptly 
referred to a transplant center for treatment.
Peer-review
This article presents one of the first known cases of hepatotoxicity associated 
with intake of the dietary supplement Garcinia cambogia. Reviewers felt the 
article was timely and well written. They requested additional information 
regarding dosage of the supplement as well as some additional discussion 
regarding its effects.
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